Merck KGaA's MilliporeSigma drops €300M on Korean biologics plant with plans to create...

cafead

Administrator
Staff member
  • cafead   Mar 21, 2024 at 06:42: PM
via A little less than a year after Merck KGaA unveiled designs on a new bioprocessing plant in South Korea, the company’s U.S.- and Canada-based life sciences business, MilliporeSigma, has swooped in with a hefty investment at the site and the promise of hundreds of new jobs.

article source
 

<